CTVIF yields 23.97% · JNJ yields 2.13%● Live data
📍 CTVIF pulled ahead of the other in Year 1
Combined, CTVIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTVIF + JNJ for your $10,000?
China Travel International Investment Hong Kong Limited, an investment holding company, provides travel and tourism services. Its Tourist Attraction and Related Operations segment operates theme parks, scenic spots, cable car systems, skiing facilities, hot spring resorts, and other resorts, as well as engages in arts performance and tourism property development activities in Mainland China. The company's Travel Agency, Travel Document, and Related Operations segment provides travel agency, travel document, and related services in Hong Kong, Mainland China, South East Asia, Oceania, the United States, and countries in the European Union. Its Hotel Operations segment offers hotel accommodation, and food and beverage services in Hong Kong, Macau, and Mainland China. The company's Passenger Transportation Operations segment provides cross-border transportation services to individuals travelling between Hong Kong, Macau, and Mainland China; and vehicle and vessel rental and charter operations in Hong Kong, Macau, and Mainland China. It also operates golf clubs; trades in computer equipment and provides computer services; and offers travel and air ticketing agency, entry permit handling agency, fuel supply, ship repairing, and logistics and courier services. In addition, the company is involved in property investment; software system development; and shipping and shipping management activities, as well as conference and exhibition operations. The company was incorporated in 1992 and is based in Central, Hong Kong. China Travel International Investment Hong Kong Limited is a subsidiary of China Travel Service (Holdings) Hong Kong Limited.
Full CTVIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.